LONDON, United Kingdom -- Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention. AstraZeneca's building in Luton, Britain (Tim Ireland | Xinhua News Agency | Getty Images) The Anglo-Swedish...